What this means
This trial is still signing up people, and no results have been posted yet. It will look at how estradiol, a hormone, may link stress and sleep changes to blood vessel health.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 40–55
- Where
- 1 site, including Delaware
The science
- Registered title
- Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women
- Trial ID
- NCT06745466 ↗
- Phase
- PHASE 4
- Study type
- interventional
- Conditions
- Estrogen, Premenopause
- What is tested
- ganirelix acetate
- Sponsor
- University of Delaware
- Ages
- 40 Years to 55 Years
- Dates
- First posted Dec 20, 2024 · updated Jul 2, 2026
Registry summary
The purpose of this study is to identify the impact of estradiol (E2) on the associations between (a) responsivity to daily stress or (b) sleep variability with vascular function in midlife premenopausal women.
Sites (1)
- University of Delaware, Newark, Delaware, United States